Cocrystal Pharma, Inc.
COCP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,049 | -$2,055 | -$2,301 | -$3,266 |
| Dep. & Amort. | $13 | $21 | $25 | $101 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $84 | $82 | $85 |
| Change in WC | $629 | -$57 | -$745 | -$12 |
| Other Non-Cash | -$142 | -$148 | $0 | -$68 |
| Operating Cash Flow | -$1,549 | -$2,155 | -$2,939 | -$3,160 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$13 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$13 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $4,541 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $4,541 | $0 | $0 | $0 |
| Forex Effect | -$16 | $0 | $0 | $0 |
| Net Chg. in Cash | $2,963 | -$2,155 | -$2,939 | -$3,160 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,841 | $6,996 | $9,935 | $13,095 |
| End Cash | $7,804 | $4,841 | $6,996 | $9,935 |
| Free Cash Flow | -$1,561 | -$2,155 | -$2,939 | -$3,160 |